SEC Form 4 · accession 0001445064-15-000088
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sandra L Hatten
Officer — Sr. VP, Quality
Period of report
May 11, 2015
Accepted (ET)
May 12, 2015 · 5:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | May 11, 2015 | M | 1,059 | $33.67 | A | 6,663 | D | |
| Ordinary Shares | May 11, 2015 | M | 1,563 | $41.73 | A | 8,226 | D | |
| Ordinary SharesF1 | May 11, 2015 | S | 2,024 | $122.29 | D | 6,202 | D | |
| Ordinary Shares | holding | — | — | — | 440 | I | By Katherine L. Weigel Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Options (Right to Buy)F2 | $33.67 | May 11, 2015 | M | 1,059 | D | — | Nov 30, 2021 | Ordinary Shares | 1,059 | 1,060 | D |
| Share Options (Right to Buy)F3 | $41.73 | May 11, 2015 | M | 1,563 | D | — | Dec 2, 2022 | Ordinary Shares | 1,563 | 2,084 | D |
Explanation of responses
- F1The price represents a weighted average. The shares were sold in multiple transactions at prices ranging from $122.26 to $122.33, inclusive. Ms. Hatten will provide, upon request of the SEC staff, Mallinckrodt plc or a shareholder of Mallinckrodt plc complete information regarding the number of shares sold at each price within the range.
- F2Options with respect to 1,059 Ordinary Shares vested on December 1, 2014.
- F3Options with respect to 521 Ordinary Shares vested on December 3, 2013 and options with respect to 1,042 Ordinary Shares vested on December 3, 2014.